These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 20636671)
81. Preferences for the delivery of community pharmacy services to help manage chronic conditions. Whitty JA; Kendall E; Sav A; Kelly F; McMillan SS; King MA; Wheeler AJ Res Social Adm Pharm; 2015; 11(2):197-215. PubMed ID: 25116938 [TBL] [Abstract][Full Text] [Related]
82. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff. Iyer P; McFarland R; La Caze A Int J Pharm Pract; 2017 Aug; 25(4):292-300. PubMed ID: 27633447 [TBL] [Abstract][Full Text] [Related]
83. A national survey exploring oral healthcare service provision across Australian community pharmacies. Freeman CR; Abdullah N; Ford PJ; Taing MW BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314 [TBL] [Abstract][Full Text] [Related]
84. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges. Lee RY; Moles R; Chaar B Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673 [TBL] [Abstract][Full Text] [Related]
85. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea. Suh HS; Lee D; Kim SY; Chee DH; Kang HY Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104 [TBL] [Abstract][Full Text] [Related]
86. Direct-to-consumer advertising: Australian pharmacists' experiences with non-prescription medicines. Chaar B; Kwong K Int J Pharm Pract; 2010 Feb; 18(1):43-50. PubMed ID: 20405595 [TBL] [Abstract][Full Text] [Related]
87. Patients' satisfaction with information and experiences with counseling on cardiovascular medication received at the pharmacy. van Geffen EC; Philbert D; van Boheemen C; van Dijk L; Bos MB; Bouvy ML Patient Educ Couns; 2011 Jun; 83(3):303-9. PubMed ID: 21550196 [TBL] [Abstract][Full Text] [Related]
88. A national mailed survey exploring weight management services across Australian community pharmacies. Fakih S; Marriott JL; Hussainy SY Aust J Prim Health; 2015; 21(2):197-204. PubMed ID: 24594078 [TBL] [Abstract][Full Text] [Related]
89. Factors influencing quality of patient interaction at community pharmacy drive-through and walk-in counselling areas. Odukoya OK; Chui MA; Pu J Int J Pharm Pract; 2014 Aug; 22(4):246-56. PubMed ID: 24164213 [TBL] [Abstract][Full Text] [Related]
90. Exploring the community pharmacist's role in palliative care: focusing on the person not just the prescription. O'Connor M; Fisher C; French L; Halkett G; Jiwa M; Hughes J Patient Educ Couns; 2011 Jun; 83(3):458-64. PubMed ID: 21621942 [TBL] [Abstract][Full Text] [Related]
91. Pharmacists' perceptions and communication of risk for alertness impairing medications. Jomaa I; Odisho M; Cheung JMY; Wong K; Ellis JG; Smyth T; Saini B Res Social Adm Pharm; 2018 Jan; 14(1):31-45. PubMed ID: 28118967 [TBL] [Abstract][Full Text] [Related]
92. Language barriers in the community pharmacy: a survey of northern and western Auckland. Chang E; Tsang B; Thornley S J Prim Health Care; 2011 Jun; 3(2):102-6. PubMed ID: 21625657 [TBL] [Abstract][Full Text] [Related]
93. Australian mental health consumers and carers expect more health management information from community pharmacy. Fejzic J; Knox K; Hattingh HL; Mey A; McConnell D; Wheeler AJ Int J Pharm Pract; 2017 Dec; 25(6):454-462. PubMed ID: 28303618 [TBL] [Abstract][Full Text] [Related]
94. Demonstrating the value of community pharmacists in New Zealand educating a targeted group of people to temporarily discontinue medicines when they are unwell to reduce the risk of acute kidney injury. Vicary D; Hutchison C; Aspden T Int J Pharm Pract; 2020 Dec; 28(6):569-578. PubMed ID: 32945014 [TBL] [Abstract][Full Text] [Related]
95. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries. Svensberg K; Sporrong SK; Björnsdottir I Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364 [TBL] [Abstract][Full Text] [Related]
96. Exploring opportunities for providing pharmacists with feedback on their practice and performance around the electronic Minor Ailments Service in Scotland. Paudyal V; Hansford D; Cunningham S; Stewart D Int J Pharm Pract; 2014 Oct; 22(5):319-26. PubMed ID: 24423237 [TBL] [Abstract][Full Text] [Related]
97. Practice change in community pharmacy: using change-management principles when implementing a pharmacy asthma management service in NSW, Australia. Feletto E; Lui GW; Armour C; Saini B Int J Pharm Pract; 2013 Feb; 21(1):28-37. PubMed ID: 23301531 [TBL] [Abstract][Full Text] [Related]
98. Community pharmacists in Australia: barriers to information provision on complementary and alternative medicines. Semple SJ; Hotham E; Rao D; Martin K; Smith CA; Bloustien GF Pharm World Sci; 2006 Dec; 28(6):366-73. PubMed ID: 17120131 [TBL] [Abstract][Full Text] [Related]
99. The role of information technology in the development of community pharmacy services: visions and strategic views of international experts. Westerling AM; Haikala V; Airaksinen M Res Social Adm Pharm; 2011 Dec; 7(4):430-7. PubMed ID: 21272534 [TBL] [Abstract][Full Text] [Related]
100. Norwegian elderly patients' need for drug information and attitudes towards medication use reviews in community pharmacies. Mamen AV; Håkonsen H; Kjome RL; Gustavsen-Krabbesund B; Toverud EL Int J Pharm Pract; 2015 Dec; 23(6):423-8. PubMed ID: 25801503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]